Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of End Stage Renal Disease Patients With Hyperkalemia

NCT03326583 is registered in ClinicalTrials.gov with Dominic Raj as lead sponsor.

NCT NCT03326583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03326583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of End Stage Renal Disease Patients With Hyperkalemia
Lead sponsor
Dominic Raj
Phase
Phase 2
Overall status
Completed
Start date
November 1, 2017
Completion date
December 31, 2020
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, esrd, hyperkalemia